Cell Genesys, National Cancer Institute, Dana-Farber Cancer Institute, University of Arizona deal

CEGE entered into three collaborations to develop its gene therapies for ovarian, colon, breast, lung and prostate cancers. The agreements

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE